OLIVER LAGORE VANVALIN INVESTMENT GROUP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
OLIVER LAGORE VANVALIN INVESTMENT GROUP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,758
+14.1%
97
+7.8%
0.01%
+25.0%
Q2 2023$10,307
-16.9%
900.0%0.00%
-20.0%
Q1 2023$12,405
+6.4%
900.0%0.01%
-28.6%
Q4 2022$11,662
+16.6%
900.0%0.01%
+16.7%
Q3 2022$10,000
+42.9%
900.0%0.01%
+50.0%
Q2 2022$7,0000.0%900.0%0.00%
-20.0%
Q1 2022$7,000900.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Ikarian Capital, LLC 399,400$35,962,0005.36%
Avoro Capital Advisors LLC 3,125,000$281,406,0004.79%
Varenne Capital Partners 324,661$29,236,0004.34%
Evolutionary Tree Capital Management, LLC 96,695$8,707,0004.18%
Ally Bridge Group (NY) LLC 120,000$10,806,0003.78%
Casdin Capital, LLC 1,350,000$121,568,0003.43%
Ghost Tree Capital, LLC 100,000$9,005,0003.23%
GREAT POINT PARTNERS LLC 145,405$13,094,0002.91%
Camber Capital Management LP 825,000$74,291,0002.55%
Alpha DNA Investment Management LLC 17,522$1,577,0001.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders